{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:08:25Z","timestamp":1778922505775,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["A20976"],"award-info":[{"award-number":["A20976"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C5759"],"award-info":[{"award-number":["C5759"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.xcrm.2025.101933","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T12:32:09Z","timestamp":1738326729000},"page":"101933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["An integrative multiparametric approach stratifies putative distinct phenotypes of blast phase chronic myelomonocytic leukemia"],"prefix":"10.1016","volume":"6","author":[{"given":"Kristian","family":"Gurashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio M.R.","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Spence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Cant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Yuan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Chin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Wedge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Montalban-Bravo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Colla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwei-Fang","family":"Tien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim C.P.","family":"Somervaille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Batta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0715-1402","authenticated-orcid":false,"given":"Daniel H.","family":"Wiseman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.101933_bib1","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2025.101933_bib2","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/leu.2015.337","article-title":"Age-related mutations and chronic myelomonocytic leukemia","volume":"30","author":"Mason","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2025.101933_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1182\/blood-2017-04-736421","article-title":"How I treat chronic myelomonocytic leukemia","volume":"130","author":"Solary","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.101933_bib4","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.3324\/haematol.2019.222059","article-title":"Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions","volume":"104","author":"Valent","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.xcrm.2025.101933_bib5","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1038\/s41375-021-01228-y","article-title":"Divergent clonal evolution of blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia from a shared TET2-mutated origin","volume":"35","author":"Batta","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2025.101933_bib6","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/ijlh.13212","article-title":"Concordance among hematopathologists in classifying blasts plus promonocytes: A bone marrow pathology group study","volume":"42","author":"Foucar","year":"2020","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.xcrm.2025.101933_bib7","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.3390\/jcm10112264","article-title":"Classification of Monocytes, Promonocytes and Monoblasts Using Deep Neural Network Models: An Area of Unmet Need in Diagnostic Hematopathology","volume":"10","author":"Osman","year":"2021","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.xcrm.2025.101933_bib8","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/PAS.0000000000001765","article-title":"IRF8 is a Reliable Monoblast Marker for Acute Monocytic Leukemias","volume":"45","author":"Katz","year":"2021","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.xcrm.2025.101933_bib9","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/cncr.34564","article-title":"A retrospective study of cladribine and low-dose cytarabine\u2013based regimens for the treatment of chronic myelomonocytic leukemia and secondary acute myeloid leukemia","volume":"129","author":"Bazinet","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.xcrm.2025.101933_bib10","doi-asserted-by":"crossref","first-page":"E433","DOI":"10.1002\/ajh.26334","article-title":"Outcomes of venetoclax-based therapy in chronic phase and blast transformed chronic myelomonocytic leukemia","volume":"96","author":"Saliba","year":"2021","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.xcrm.2025.101933_bib11","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/s41375-021-01240-2","article-title":"Activity of venetoclax-based therapy in chronic myelomonocytic leukemia","volume":"35","author":"Montalban-Bravo","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2025.101933_bib12","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1200\/JCO.2017.77.6112","article-title":"CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia","volume":"36","author":"Lancet","year":"2018","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.101933_bib13","doi-asserted-by":"crossref","first-page":"e481","DOI":"10.1016\/S2352-3026(21)00134-4","article-title":"CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial","volume":"8","author":"Lancet","year":"2021","journal-title":"Lancet. Haematol."},{"key":"10.1016\/j.xcrm.2025.101933_bib14","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/modpathol.2012.218","article-title":"Clinicopathologic analysis of acute myeloid leukemia arising from chronic myelomonocytic leukemia","volume":"26","author":"Courville","year":"2013","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.xcrm.2025.101933_bib15","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1038\/s41375-018-0143-8","article-title":"Blast Phase Chronic Myelomonocytic Leukemia: Mayo-MDACC Collaborative study of 171 cases","volume":"32","author":"Patnaik","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2025.101933_bib16","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1182\/blood-2021-153941","article-title":"Clinical Characteristics and Contemporary Outcomes of Acute Myeloid Leukemia Evolving from Chronic Myelomonocytic Leukemia","volume":"138","author":"Hammond","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.101933_bib17","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.101933_bib18","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1634\/stemcells.2007-0250","article-title":"Transcriptional Analysis of Quiescent and Proliferating CD34+ Human Hemopoietic Cells from Normal and Chronic Myeloid Leukemia Sources","volume":"25","author":"Graham","year":"2007","journal-title":"Stem Cell."},{"key":"10.1016\/j.xcrm.2025.101933_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109698","article-title":"Transitions in lineage specification and gene regulatory networks in hematopoietic stem\/progenitor cells over human development","volume":"36","author":"Roy","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2025.101933_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/ncb3493","article-title":"Human haematopoietic stem cell lineage commitment is a continuous process","volume":"19","author":"Velten","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.101933_bib21","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","article-title":"Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity","volume":"176","author":"van Galen","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.101933_bib22","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ccell.2022.07.002","article-title":"Integrative analysis of drug response and clinical outcome in acute myeloid leukemia","volume":"40","author":"Bottomly","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.101933_bib23","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.leukres.2009.01.027","article-title":"The anti-apoptotic role of the unfolded protein response in Bcr-Abl-positive leukemia cells","volume":"33","author":"Tanimura","year":"2009","journal-title":"Leuk. Res."},{"key":"10.1016\/j.xcrm.2025.101933_bib24","doi-asserted-by":"crossref","first-page":"18736","DOI":"10.18632\/oncotarget.7702","article-title":"Inhibition of IRE1\u03b1-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia","volume":"7","author":"Sun","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2025.101933_bib25","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.3390\/ijms20236003","article-title":"The Role of Reactive Oxygen Species in Acute Myeloid Leukaemia","volume":"20","author":"Sillar","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2025.101933_bib26","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.3390\/jcm9092934","article-title":"Targeting PI3K\/Akt\/mTOR in AML: Rationale and Clinical Evidence","volume":"9","author":"Darici","year":"2020","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.xcrm.2025.101933_bib27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3390\/cancers12020333","article-title":"The Unfolded Protein Response: A Novel Therapeutic Target in Acute Leukemias","volume":"12","author":"Martelli","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.xcrm.2025.101933_bib28","first-page":"1176","article-title":"Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells","volume":"1","author":"Stevens","year":"2020","journal-title":"Nat. Can. (Ott.)"},{"key":"10.1016\/j.xcrm.2025.101933_bib29","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200924","article-title":"Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia","volume":"218","author":"Stuani","year":"2021","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2025.101933_bib30","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1182\/bloodadvances.2021005938","article-title":"Bone marrow stroma cells promote induction of a chemoresistant and prognostic unfavorable S100A8\/A9high AML cell subset","volume":"6","author":"B\u00f6ttcher","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.xcrm.2025.101933_bib31","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1182\/blood.2020008729","article-title":"Cytokine-like protein 1\u2013induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMML","volume":"137","author":"Sevin","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.101933_bib32","article-title":"Targeting MCL1-driven anti-apoptotic pathways to overcome hypomethylating agent resistance in RAS -mutated chronic myelomonocytic leukemia","author":"Montalban-Bravo","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2025.101933_bib33","first-page":"826","article-title":"Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia","volume":"1","author":"Zhang","year":"2020","journal-title":"Nat. Can. (Ott.)"},{"key":"10.1016\/j.xcrm.2025.101933_bib34","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1158\/2159-8290.CD-20-1375","article-title":"Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence","volume":"11","author":"Duy","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2025.101933_bib35","series-title":"ASH","article-title":"The Role of Quiescence in Acute Myeloid Leukemia Growth","author":"Restelli","year":"2022"},{"key":"10.1016\/j.xcrm.2025.101933_bib36","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1182\/blood.2021012519","article-title":"Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformation","volume":"139","author":"You","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.101933_bib37","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/bjh.19060","article-title":"Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic leukaemia","volume":"203","author":"Montalban-Bravo","year":"2023","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.xcrm.2025.101933_bib38","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/bjh.18681","article-title":"A three-gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemia","volume":"201","author":"Wang","year":"2023","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.xcrm.2025.101933_bib39","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/leu.2017.38","article-title":"Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin","volume":"31","author":"Brunetti","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2025.101933_bib40","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa1815105","article-title":"Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm","volume":"380","author":"Pemmaraju","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.101933_bib41","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1182\/bloodadvances.2019000647","article-title":"How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?","volume":"3","author":"Garnache-Ottou","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.xcrm.2025.101933_bib42","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ccell.2015.07.017","article-title":"Frequent Derepression of the Mesenchymal Transcription Factor Gene FOXC1 in Acute Myeloid Leukemia","volume":"28","author":"Somerville","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.101933_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113112","article-title":"IL-6 promotes chemoresistance via upregulating CD36 mediated fatty acids uptake in acute myeloid leukemia","volume":"415","author":"Zhang","year":"2022","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.xcrm.2025.101933_bib44","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/cr.2009.129","article-title":"S100A8\/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3","volume":"20","author":"Ghavami","year":"2010","journal-title":"Cell Res."},{"key":"10.1016\/j.xcrm.2025.101933_bib45","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1038\/s41375-019-0504-y","article-title":"Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AML","volume":"33","author":"Karjalainen","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2025.101933_bib46","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/2159-8290.CD-19-0710","article-title":"Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia","volume":"10","author":"Pei","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2025.101933_bib47","doi-asserted-by":"crossref","DOI":"10.1172\/JCI152673","article-title":"Bone marrow\u2013confined IL-6 signaling mediates the progression of myelodysplastic syndromes to acute myeloid leukemia","volume":"132","author":"Mei","year":"2022","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2025.101933_bib48","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1182\/blood-2021-151535","article-title":"Anti-B7-H3 Antibody (T-1A5) Blocks Immunomodulatory Function of B7-H3 and Enhances NK Cell-Mediated Cytotoxicity Against Acute Myeloid Leukemia Cells","volume":"138","author":"Tyagi","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.101933_bib49","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1158\/1078-0432.CCR-20-2540","article-title":"Preclinical Evaluation of B7-H3\u2013specific Chimeric Antigen Receptor T Cells for the Treatment of Acute Myeloid Leukemia","volume":"27","author":"Lichtman","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.101933_bib50","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41591-020-0910-8","article-title":"Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents","volume":"26","author":"Riether","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.101933_bib51","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1034\/j.1600-0609.2001.00553.x","article-title":"FAB M4 and high CD14 surface expression is associated with high cellular resistance to Ara-C and daunorubicin: implications for clinical outcome in acute myeloid leukaemia","volume":"67","author":"N\u00f8rgaard","year":"2001","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.xcrm.2025.101933_bib52","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1186\/s12885-022-10073-w","article-title":"The ABNL-MARRO 001 study: a phase 1\u20132 study of randomly allocated active myeloid target compound combinations in MDS\/MPN overlap syndromes","volume":"22","author":"Moyo","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.xcrm.2025.101933_bib53","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2025.101933_bib54","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/bjh.12511","article-title":"Very high frequencies of leukaemia-initiating cells in precursor T-acute lymphoblastic leukaemia may be obscured by cryopreservation","volume":"163","author":"Greystoke","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.xcrm.2025.101933_bib55","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2025.101933_bib56","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.xcrm.2025.101933_bib57","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.101933_bib58","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.celrep.2017.06.067","article-title":"Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes","volume":"20","author":"Unnikrishnan","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2025.101933_bib59","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1172\/JCI130809","article-title":"A stress-responsive enhancer induces dynamic drug resistance in acute myeloid leukemia","volume":"130","author":"Williams","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2025.101933_bib60","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.1111\/jcmm.14608","article-title":"Identification of predictive genetic signatures of Cytarabine responsiveness using a 3D acute myeloid leukaemia model","volume":"23","author":"Xu","year":"2019","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.xcrm.2025.101933_bib61","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","article-title":"Acute myeloid leukemia: current progress and future directions","volume":"11","author":"Kantarjian","year":"2021","journal-title":"Blood Cancer J."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125000060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125000060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:18:14Z","timestamp":1778919494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125000060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2666379125000060"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.101933","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An integrative multiparametric approach stratifies putative distinct phenotypes of blast phase chronic myelomonocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.101933","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101933"}}